Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umair Mahmood

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancers|February 24, 2024
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid BiopsiesUmair Mahmood, Elisya Muhamad Faizul, Sarah Howlett, et al.
Cancer Treatment Reviews|April 28, 2026
Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastasesAlex B Munster, Umair Mahmood, Heather Fuller, et al.
Oral Oncology|July 27, 2019
Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancerGlenn J Hanna, Christie J Lau, Umair Mahmood, et al.
Cancers|June 13, 2025
Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre StudyUmair Mahmood, Joanna Lynch, Simran Kaur Sandhu, et al.
Scientific Reports|March 8, 2017
Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani populationMohsin Shahzad, Sairah Yousaf, Yar M Waryah, et al.
Cancers|January 10, 2026
Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational ExperienceUmair Mahmood, Eleni Josephides, Nicholas Coupe, et al.
Cancers|September 13, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre StudyUmair Mahmood, Eleni Josephides, Meenali Chitnis, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint BlockadeUmair Mahmood, Mai Anh Huynh, Joseph H Killoran, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Ebiomedicine|July 16, 2024
Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictorsEnric Domingo, Sanjay Rathee, Andrew Blake, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|February 24, 2024
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid BiopsiesUmair Mahmood, Elisya Muhamad Faizul, Sarah Howlett, et al.
Cancer Treatment Reviews|April 28, 2026
Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastasesAlex B Munster, Umair Mahmood, Heather Fuller, et al.
Oral Oncology|July 27, 2019
Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancerGlenn J Hanna, Christie J Lau, Umair Mahmood, et al.
Cancers|June 13, 2025
Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre StudyUmair Mahmood, Joanna Lynch, Simran Kaur Sandhu, et al.
Scientific Reports|March 8, 2017
Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani populationMohsin Shahzad, Sairah Yousaf, Yar M Waryah, et al.
Cancers|January 10, 2026
Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational ExperienceUmair Mahmood, Eleni Josephides, Nicholas Coupe, et al.
Cancers|September 13, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre StudyUmair Mahmood, Eleni Josephides, Meenali Chitnis, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint BlockadeUmair Mahmood, Mai Anh Huynh, Joseph H Killoran, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Ebiomedicine|July 16, 2024
Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictorsEnric Domingo, Sanjay Rathee, Andrew Blake, et al.
Pageof 3